Introduction:
Cervical cancer is the most common cause of preventable cancer related deaths; cervical cancer has a long pervasive phase (cervical
dysplasia); the prevalence of cervical dysplasia varies according to the
socioeconomic characteristics and geographic
areas of the population studied. Low-grade lesions regress spontaneously
in a significant number of patients, while high grade lesions will progress to
an invasive cancer if left untreated. Cervical cancer screening is an important
component of the World Health Organization (WHO) strategy for combating
cervical cancer. The incidence and prevalence of cervical cancer has reduced
remarkably over the last three decades in developed countries where there are
effective, well-coordinated screening programs, and treatment of cervical
dysplasia, while in developing countries it has been increasing and has
constituted major health problems among women
where there are no well-coordinated and effective screening programs,
also resources are very low and no insurance can cover this programs. Aim of
the work: The aim is to assess the prevalence of abnormal cervical cytology in
Al Shatby Maternity University Hospital patients using Pap smear. Materials and
methods: Inclusion criteria: 1) Married woman from 3 years or more; 2) Women
age from 21 to age 65 years. Exclusion criteria: 1) Previously known cervical
cancer patient; 2) Virgin females; 3) Woman with active vaginal bleeding.
Results: 83% of patients were -ve intraepithelial neoplasia {37.7% was
normal cytology and 45.3% was inflammatory}. 17% was +ve intraepithelial
neoplasia (abnormal cytology), {11.1% ASCUS, 2.9% LSIL, 1.3% HSIL, 1.1% ASC-H,
0.3% AGS-NO, 0.3% AGS-Favour Neoplastic}. Prevalence of abnormal cervical
cytology in age group less than30 years was 8.4% which is lower than prevalence
in the middle age group which was 19.9%. Prevalence of abnormal cervical
cytology in women with normal vaginal delivery was higher than those with
caesarean delivery. 39.8% of our patients were passive and active smokers 61.2%
of their Pap smear was abnormal cytology. 78.9% of abnormal cytology was among patients from low socioeconomic class
(rural
References
[1]
Ferlay, J., Soerjomataram, I., Dikshit, R., et al. (2015) Cancer Incidence and Mortality Worldwide: Sources, Methods and Major Patterns in GLOBOCAN 2012. International Journal of Cancer, 136, E359-E386. https://doi.org/10.1002/ijc.29210
[2]
(2013) Human Papillomavirus and Related Cancers, Fact Sheet. ICO HPV Information Centre Institut Català d’Oncologia.
[3]
Tainio, K., Athanasiou, A., Tikkinen Kari, A.O., et al. (2018) Clinical Course of Untreated Cervical Intraepithelial Neoplasia Grade 2 under Active Surveillance: Systematic Review and Meta-Analysis. BMJ, 360, 499. https://doi.org/10.1136/bmj.k499
[4]
IARC Working Group on the Evaluation of Carcinogenic Risk to Humans (2012) Biological Agents. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 100B, International Agency for Research on Cancer, Lyon.
https://www.ncbi.nlm.nih.gov/books/NBK304348
[5]
Schneider, V. (2017) Criticism of the Pap Smear as a Diagnostic Tool in Cervical Cancer Screening. Acta Cytologica, 61, 338-344. https://doi.org/10.1159/000477653
[6]
Naya, R. and Wilbur, D.C. (2015) The Pap Test and Bethesda 2014. Cancer Cytopathology, 123, 271-281. https://doi.org/10.1002/cncy.21521
[7]
Kotz, S., Balakrishnan, N., Read, C.B., et al. (2006) Encyclopedia of Statistical Sciences. 2nd Edition, Wiley-Interscience, Hoboken.
[8]
Sudenga, S.L., Rositch, A.F., Otieno, W.A. and Smith, J.S. (2013) Knowledge, Attitudes, Practices, and Perceived Risk of Cervical Cancer among Kenyan Women: Brief Report. International Journal of Gynecological Cancer, 23, 895-899.
https://doi.org/10.1097/IGC.0b013e31828e425c
[9]
Idowu, A., Olowookere, S.A., Fagbemi, A.T., et al. (2016) Determinants of Cervical Cancer Screening Uptake among Women in Ilorin, North Central Nigeria: A Community-Based Study. Journal of Cancer Epidemiology, 2016, Article ID: 6469240. https://doi.org/10.1155/2016/6469240
[10]
Forouzanfar, M.H., Foreman, K.J., Delossantos, A.M., et al. (2011) Breast and Cervical Cancer in 187 Countries between 1980 and 2010: A Systematic Analysis. The Lancet, 378, 1461-1484. https://doi.org/10.1016/S0140-6736(11)61351-2
[11]
Campos, N.G., Tsu, V., Jeronimo, J., et al. (2017) Evidence-Based Policy Choices for Efficient and Equitable Cervical Cancer Screening Programs in Low-Resource Settings. Cancer Medicine, 6, 2008-2014. https://doi.org/10.1002/cam4.1123
[12]
Lewis, M.J. (2011) A Situational Analysis of Cervical Cancer in Latin America and the Caribbean. Obstetrics and Gynecology Clinics of North America, 39, 1-29.
[13]
WHO (2017) Comprehensive Cervical Cancer Control: A Guide to Essential Practices. Geneva.
[14]
Cronjé, H.S. (2017) Screening for Cervical Cancer in Developing Countries. International Journal of Gynecology & Obstetrics, 84, 101-108.
https://doi.org/10.1016/j.ijgo.2003.09.009
[15]
Holowaty, P., Miller, A.B., Rohan, T., et al. (2017) Natural History of Dysplasia of the Uterine Cervix. Journal of the National Cancer Institute, 91, 252-258.
https://doi.org/10.1093/jnci/91.3.252
[16]
Mosuro, O.A., Ajayi, I., Odukogbe, A.T.A., et al. (2015) Prevalence of Cervical Dysplasia and Associated Risk Factors among Women Presenting at a Primary Care Clinic in Nigeria. Journal of Basic and Clinical Reproductive Sciences, 4, 70-79.
https://doi.org/10.4103/2278-960X.161053
[17]
Richter, K., Becker, P., Horton, A., et al. (2013) Age-Specific Prevalence of Cervical Human Papillomavirus Infection and Cytological Abnormalities in Women in Gauteng Province, South Africa. South African Medical Journal, 103, 313-317.
https://doi.org/10.7196/SAMJ.6514
[18]
Sanad, A.S., Kamel, H.H. and Hasan, M.M. (2014) Prevalence of Cervical Intraepithelialneoplasia (CIN) in Patients Attending Minia Maternity University Hospital. Archives of Gynecology and Obstetrics, 289, 1211-1217.
https://doi.org/10.1007/s00404-013-3109-0
[19]
American Cancer Society. American Cancer Society Prevention, Early Detection, and Survivorship Guidelines.
http://www.cancer.org/healthy/informationforhealthcareprofessionals/acsguidelines/index
[20]
El Mahalli, A.A. (2015) Incidence and Risk Factors of Abnormal Cervical Cytology in a University Hospital—Saudi Arabia. Saudi Journal for Health Sciences, 4, 104-110. https://doi.org/10.4103/2278-0521.157878
[21]
El-Moselhy, E.A., Salim, S.A. and Hagrass, S.A. (2017) Prevalence and Risk Factors of Cervical Intraepithelial Neoplasia and Cervical Cancer among Ever Married Adult Females in Egypt: A Survey Study. Journal of Comprehensive Cancer Research, 1, Article ID: 100002.
[22]
Skegg, D.C., Crowin, P.A. and Paul, C. (2003) Importance of the Male Factor of Cancer Cervix. The Lancet, 362, 583-589.
[23]
Vaccarella, S., Herrero, R., Snijders, P.J., et al. (2008) Smoking and Human Papillomavirus Infection: Pooled Analysis of the International Agency for Research on Cancer HPV Prevalence Surveys. International Journal of Epidemiology, 37, 536-554.
https://doi.org/10.1093/ije/dyn033
[24]
Min, K.-J. (2018) Association between Passive Smoking and the Risk of Cervical Intraepithelial Neoplasia 1 in Korean Women. Journal of Epidemiology, 28, 48-53. https://doi.org/10.2188/jea.JE20160118
[25]
El-Moselhy, E.A., Borg, H.M. and Atlam, S.A. (2016) Cervical Cancer: Sociodemographic and Clinical Risk Factors among Adult Egyptian Females. Advanced Oncology Research and Treatment, 1, 106.
[26]
Castellsagué, X., Daz, M., Vaccarella, S., et al. (2011) Intrauterine Device Use, Cervical Infection with Human Papillomavirus, and Risk of Cervical Cancer: A Pooled Analysis of 26 Epidemiological Studies. The Lancet Oncology, 12, 1023-1031.
https://doi.org/10.1016/S1470-2045(11)70223-6
[27]
Boyles, S. (2011) IUDs for Birth Control May Cut Cervical Cancer Risk. WebMD Health News.
http://www.webmd.com/sex/birth-control/news/20110912/iud-for-birth-control-may-cut-cervical-cancer-risk
